Blauvelt, NY (Nov 13, 2013) – RFI and Ilhwa North America are pleased to announce that an independent expert panel has given GS15-4™, the “21st Century Ginseng,” self-affirmed GRAS (Generally Recognized as Safe) status. After a comprehensive evaluation of research studies and toxicology data, the panel concluded that GS15-4™ is safe for use as an ingredient in a variety of products including beverages, confectionery products, dietary supplements and nutritional bars. According to the FDA, self-affirmed GRAS status is awarded to any substance that is generally recognized among qualified experts as having been adequately shown to be safe under the conditions of its intended use and is manufactured in accordance with current Good Manufacturing Practices.
“GS15-4™ is a breakthrough technology using enzyme fermentation to produce a completely balanced ginseng extract in its end-stage metabolite form,” said David C. Konn, President of Ilhwa North America. “Human clinical studies have proven that it provides 15 times higher absorption, four times faster absorption and five times more consistent absorption.”
“Ginseng has been one of the top-selling herbal supplements for years. With self-affirmed GRAS status, we can now offer an improved, more bioavailable ginseng for use in many more applications,” said Jeff Wuagneux, RFI’s President and CEO. RFI is the exclusive manufacturing, formulation and sales partner of Ilhwa NA Inc., a wholly-owned U.S. subsidiary of Korea’s groundbreaking leader in ginseng science, Ilhwa.
For more information, visit both companies at RFI’s booth (#24035) at Supply Side West.
Established in 1989, RFI is headquartered in Blauvelt, NY. RFI is a formulation-driven company specializing in exceptional products, services and solutions for the dietary supplement, food and beverage industries. Its experienced staff, state-of-the-art facilities and advanced technologies help its customers develop, manufacture and market complete and targeted products. By capitalizing on its natural, organic and science-driven ingredients, existing expertise and global network of manufacturing facilities, RFI does more than just sell ingredients…it offers turnkey products using its Field to Formula® vertically-integrated model. RFI’s extensive network of manufacturing facilities in North America, South America and China provides customers with multiple natural product ingredient solutions worldwide. For more information regarding RFI products, call 800-962-7663 or visit online at www.rfiingredients.com.
Ilhwa Co. Ltd., is a high-tech pharmaceutical and nutraceutical company with three divisions: Ginseng, Pharmaceuticals and Beverages. Through continuous scientific research and development for more than four decades, it has become the world leader in ginseng science. Ilhwa is fully KFDA compliant and GMP and ISO certified, holding numerous patents and the publications of hundreds of papers and clinical studies. In 2011, Ilhwa received KFDA approval for a “certified health claim” on it new enzyme fermented ginseng extract to claim, “helps to manage blood glucose.” Ilhwa is the first ginseng company to receive this certification.